Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


De Maria

Leonardo De Maria, Bagsvaerd DK

Patent application numberDescriptionPublished
20110003333Method for Increasing Expression Yield of a Protein of Interest - The present invention relates to a method of producing a protein of interest comprising: (a) cultivating a mutant cell under conditions conducive for production of the protein wherein the mutant has a reduced or no expression of an endogenous polypeptide shown in SEQ ID NO: 2 compared to a parent host cell grown under the same conditions; and optionally (b) recovering the protein of interest.01-06-2011

Massimo De Maria, Oggiona S. Stefano Va IT

Patent application numberDescriptionPublished
20090238028Method for producing composite materials such as thermoplastic resins with mineral and/or vegetable fillers - A method for producing composite materials, such as thermoplastic resins with mineral and/or vegetable fillers, consisting in feeding a mineral and/or vegetable filler, preheating the filler, feeding a melted thermoplastic resin onto the filler, introducing the mixture of the filler and the thermoplastic resin in an extruder, subjecting the mixture to high compression, producing a high partial vacuum, and compressing the mixture in an extrusion head, out of which the material to be subjected to subsequent treatments flows.09-24-2009

Massimo De Maria, Oggiona Con Santo Stefano IT

Richard P. De Maria, Highland Mills, NY US

Patent application numberDescriptionPublished
20080233213Hair sustaining formulation - A multi-dimensional hair sustaining formulation having a liquid transport agent that carries multi-ingredients to hair follicles in order to prevent Dihydrotestosterone (DHT) from attaching to receptor sites on the follicles of existing hair, hence promoting the growth of existing hair which otherwise would succumb to DHT attack.09-25-2008

Ruggero De Maria, Rome IT

Patent application numberDescriptionPublished
20080254488Cancer Test - The CD133 marker has been found to be diagnostic of malignant lung cancers. Tests and kits to show such cells and uses for such cells are disclosed.10-16-2008
20090275546Diagnostic tests and personalized treatment regimes for cancer stem cells - Provided are methods of identifying a metabolic target in a cancer stem cell that include using a microarray to identify intracellular signaling networks within a population of cancer stem cells that respond to a growth factor for the stem cell. Also provided are methods of determining a personalized therapeutic regime that include receiving metabolic information relating to a cancer stem cell in a patient, determining the patient's personal criteria relevant to the therapeutic regime, and combining the metabolic and personal criteria. Also provided are a diagnostic test for establishing a personalized therapeutic regime for a colon cancer patient and methods of reducing colon cancer stem cells/treating colon cancer.11-05-2009
20100016406Antisense RNA for Treating Cancer and Inhibition of Metastasis and Vectors for Antisense Sequestration - Provided is the use of antisense RNA and methods for the treatment, diagnosis and prophylaxis of cancer comprising administering said antisense RNA, particularly miRs 15 and 16 to a patient in need thereof.01-21-2010
20110123499CELLULAR DIFFERENTIATION PROMOTION - Neural precursor cells can be encouraged to form mature neural cells twice as quickly in the absence, or reduced expression of, thymosin β4.05-26-2011

Patent applications by Ruggero De Maria, Rome IT